导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 106.92% | 52/4484 |
| 近一周 | 9.40% | 55/5079 |
| 近一月 | 7.74% | 181/5013 |
| 近一季 | 7.64% | 582/4886 |
| 近半年 | 112.54% | 30/4661 |
| 近一年 | 95.57% | 62/4456 |
| 近两年 | 129.07% | 56/3963 |
| 近三年 | 89.46% | 69/3306 |
| 成立以来 | 90.82% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
3.16% 2463/4617 |
4.36% 1471/4794 |
74.85% 54/4965 |
- - |
| 2024 | 14.69% 588/4611 |
-1.38% 1761/4340 |
-0.25% 1452/4440 |
11.40% 1810/4543 |
4.65% 647/4611 |
| 2023 | -16.52% 2140/4209 |
5.50% 905/3759 |
4.91% 185/3909 |
-18.69% 3693/4055 |
-7.24% 3054/4209 |
| 2022 | -31.81% 2452/3571 |
-19.66% 1843/2804 |
9.78% 1018/3205 |
-17.35% 2781/3430 |
-6.45% 2846/3570 |
| 2021 | -10.94% 1416/2712 |
0.96% 272/1745 |
-3.66% 1718/2232 |
-5.98% 1313/2560 |
-2.62% 1949/2708 |
| 2020 | 43.63% 691/1591 |
-10.55% 952/1036 |
12.16% 940/1256 |
23.95% 33/1472 |
15.50% 607/1690 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8141 | 37.76% |
| 易方达标普生物科技人民币A | 1.7328 | 28.02% |
| 永赢先锋半导体智选混合发起C | 1.2684 | 26.99% |
| 银华集成电路混合A | 1.4951 | 23.93% |
| 华商致远回报混合A | 1.6291 | 23.20% |
| 华夏中证半导体材料设备主题ETF | 1.5851 | 22.62% |
| 天弘中证半导体材料设备主题指数发起C | 1.7561 | 21.34% |
| 诺安优化配置混合A | 2.5072 | 17.29% |
| 东方低碳经济混合C | 1.2657 | 17.06% |
| 广发生物科技指数美元(QDII)A | 0.2092 | 16.76% |
| 永赢高端制造混合C VS. () |